George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 24.00
Ask: 25.00
Change: -1.00 (-3.92%)
Spread: 1.00 (4.167%)
Open: 25.50
High: 25.50
Low: 24.50
Prev. Close: 25.50
RENX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Renalytix Plc

14 Mar 2024 07:32

Form 8.5 (EPT/RI) - Renalytix Plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeRenalytix plc
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Joint Broker to Renalytix plc
(d) Date dealing undertaken: 13th March 2024
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A” N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid / received (pence)Lowest price per unit paid / received (pence)
Ordinary Shares Purchase 11,000 30 30
Ordinary Shares Sales 4,576 28.84 28.84

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
    

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
 

Date of disclosure:14th March 2024
Contact name:Rich White
Telephone number:+44 207 597 5462

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

Date   Source Headline
26th Apr 20245:34 pmRNSHolding(s) in Company
26th Apr 20244:32 pmRNSForm 8.3 - Renalytix PLC
26th Apr 20244:25 pmRNSHolding(s) in Company
26th Apr 202412:09 pmRNSForm 8.3 - Renalytix plc
26th Apr 202412:07 pmRNSForm 8.3 - Renalytix plc
26th Apr 202412:05 pmRNSForm 8.3 -Renalytix plc
26th Apr 202412:05 pmRNSForm 8.3 - Renalytix plc
26th Apr 202412:04 pmRNSForm 8.3 - Renalytix PLC
26th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
26th Apr 202411:39 amPRNForm 8.3 - Renalytix PLC
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
26th Apr 20247:59 amRNSForm 8.3 - Renalytix PLC
25th Apr 20242:22 pmRNSAllotment and issue of Second Tranche Shares
25th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
25th Apr 20246:45 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
24th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
24th Apr 20247:38 amGNWForm 8.5 (EPT/RI) - Renalytix plc
23rd Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
22nd Apr 20245:27 pmRNSIssue of Shares and Rule 2.9 Announcement
22nd Apr 20244:09 pmRNSResult of General Meeting
22nd Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
18th Apr 20241:13 pmRNSForm 8.3 - Renalytix plc
18th Apr 20247:00 amRNSManagement Change
17th Apr 20245:17 pmRNSForm 8.3 - Renalytix plc
17th Apr 20242:57 pmRNSForm 8.3 - Renalytix plc
17th Apr 20242:29 pmRNSForm 8.3 - Renalytix PLC
17th Apr 20242:27 pmRNSForm 8.3 - Renalytix plc
16th Apr 20241:08 pmRNSRule 2.9 Announcement
16th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
15th Apr 20245:58 pmRNSForm 8.3 - Renalytix plc
15th Apr 20244:23 pmRNSHolding(s) in Company
15th Apr 20243:54 pmRNSCompletion of Financing and Total Voting Rights
15th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
15th Apr 20247:46 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
12th Apr 20243:51 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSRule 2.9 Announcement
10th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
10th Apr 202410:00 amRNSIssue of Shares
9th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
9th Apr 20247:24 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
8th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
8th Apr 20247:50 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
8th Apr 20247:44 amRNSFinancing with Expected Size of up to $4 Million
5th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
5th Apr 202411:39 amRNSChange of Registered Address
4th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
4th Apr 20247:31 amGNWForm 8.5 (EPT/RI) - Renalytix plc
3rd Apr 20243:02 pmRNSNotice of GM
3rd Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
3rd Apr 20247:46 amGNWForm 8.5 (EPT/RI) - Renalytix plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.